DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow Involvement.

Aptamer Therapeutics in Cancer: Current and Future.

A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor Cells.

Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models.

Thioaptamer targeted discoidal microparticles increase self immunity and reduce Mycobacterium tuberculosis burden in mice.

A Unique and Simple Approach to Improve Sensitivity in (15)N-NMR Relaxation Measurements for NH₃⁺ Groups: Application to a Protein-DNA Complex.

Development of Phosphorothioate DNA and DNA Thioaptamers.

Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophrenia.

Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia.

X-Aptamer Selection and Validation.

E-selectin Targeting PEGylated-thioaptamer Prevents Breast Cancer Metastases.

l-Proline, GABA Synthesis and Gamma Oscillations in Schizophrenia.

Morph-X-Select: Morphology-based tissue aptamer selection for ovarian cancer biomarker discovery.

Altered expression of developmental regulators of parvalbumin and somatostatin neurons in the prefrontal cortex in schizophrenia.

Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy.